###begin article-title 0
###xml 20 28 <span type="species:ncbi:9606">patients</span>
Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 207 215 207 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2</italic>
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
Mutations in COL8A2 gene which encodes the collagen alpha-2 (VIII) chain have been identified in both familial and sporadic cases of Fuchs endothelial corneal dystrophy (FECD). Heterozygous mutations in the SLC4A11 gene are also known to cause late-onset FECD. Therefore we screened for COL8A2, SLC4A11 gene variants in Indian FECD patients.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2</italic>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
Eighty patients with clinically diagnosed FECD and 100 age matched normal individuals were recruited. Genomic DNA was isolated from peripheral blood leukocytes. Mutations in COL8A2, SLC4A11 coding regions were screened using bi-directional sequencing. Fischer's exact test or Pearson's chi squared test were used to predict the statistical association of genotypes with the phenotype.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
Screening of COL8A2 gene revealed 2 novel c.1610G>A, c.1643A>G and 3 reported variations c.112G>A, c.464G>A and c.1485G>A. In SLC4A11 gene, novel c.1659C>T, c.1974C>T and reported c.405G>A, c.481A>C and c.639G>A variants were identified. However all the variations in both the genes were also present in unaffected controls.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2</italic>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2</italic>
###xml 299 307 299 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 348 356 <span type="species:ncbi:9606">patients</span>
This is the first study analysing COL8A2 gene in Indian patients with FECD. No pathogenic mutations were identified in COL8A2. Merely silent changes, which showed statistically insignificant association with FECD, were identified in the screening of SLC4A11 gene. These results suggest that COL8A2, SLC4A11 genes may not be responsible for FECD in patients examined in this study.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
The corneal endothelial dystrophies comprising Fuchs endothelial corneal dystrophy (FECD; MIM#s 136800 and 610158), posterior polymorphous corneal dystrophy (PPCD; MIM#s 122000, 609140 and 609141) and congenital hereditary endothelial dystrophy (CHED; MIM121700 and 217700) are thought to represent defects of neural crest terminal differentiation [1]. FECD is a degenerative, bilateral, often asymmetric and slowly progressive disorder [2]. It is characterized by a pleomorphic, attenuated, dysfunctional and degenerated corneal endothelium and the progressive formation of microscopic, refractile, posterior excrescences in the Descemet membrane (a collagen rich basal lamina) secreted by corneal endothelium, clinically known as corneal guttae [3]. Due to endothelial dysfunction and loss of cells with FECD progression leads to corneal decompensation and impaired vision [4].
###end p 10
###begin p 11
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
FECD may show familial clustering but it is usually a sporadic condition [5,6]. It occurs predominantly in females compared to the males [2,7]. Corneal grafting is the only means of restoring vision in advanced cases, however there is always the risk for allograft rejection and requires lifelong follow up.
###end p 11
###begin p 12
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 560 567 560 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
###xml 800 808 <span type="species:ncbi:9606">patients</span>
The genotypic approach will provide better understanding, identification of the underlying genetic defects and in future enhance the possibility of medical intervention using conventional pharmacological approaches or gene therapy. Family based studies have mapped late-onset FECD susceptibility loci to 13ptel-13q12.13 [8] and 18q21.2-q21.32 [9]. Genome wide linkage analysis of 22 families with FECD identified potential linkage regions on chromosomes 1, 7, 15, 17, and X [10]. Recently FECD is linked to a novel locus on 5q33.1-q35.2 [11]. Mutations in the COL8A2 gene located on 1p34.3 have been described in patients with FECD [12-16]. This gene encodes for the collagen alpha- 2 (VIII) chain, a major component of Descemet membrane. This protein is found in the posterior banded layer (PBL) of patients with FECD [17,18].
###end p 12
###begin p 13
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 110 118 110 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Heterozygous mutations in the SLC4A11 gene are also known to be associated with the late-onset FECD [19]. The SLC4A11 gene, which codes for sodium bicarbonate transporter-like protein 11 have been previously associated with autosomal recessive congenital hereditary endothelial dystrophy (CHED2) that also arises by the primary defect in the corneal endothelium [20].
###end p 13
###begin p 14
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 219 227 219 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 528 536 528 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 590 598 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 515 523 <span type="species:ncbi:9606">patients</span>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
Susceptibility of genes to mutations can vary in different ethnicities and also in view of the limited information on the genetics of FECD from India, we undertook this study. We screened for mutation in the COL8A2 and SLC4A11 genes to determine whether these genes are responsible for causing FECD in Indian population. We report for the first time, the results of mutation analysis of the COL8A2 gene in 80 unrelated patients with early onset & late onset FECD. A study by Vithana et al., screened 25 Indian FECD patients for SLC4A11 mutations [19], this is the first report of analysing SLC4A11 gene in a larger series of Indian patients having FECD.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 16
###begin p 17
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 512 520 <span type="species:ncbi:9606">patients</span>
###xml 769 777 <span type="species:ncbi:9606">patients</span>
All the patients and normal controls screened were recruited from Aravind Eye Hospital (A tertiary eye care centre), Madurai, Tamilnadu, India. Eighty patients studied were sporadic cases of Indian ancestry. One hundred control individuals without any eye disease were enlisted. The study protocol had the approval of Institutional Review Board of Aravind Eye Hospital. Informed consent was obtained from each individual and all studies were performed according to the tenets of the Declaration of Helsinki. All patients underwent a complete ophthalmic evaluation including a detailed medical and family history. The presence of guttae was identified using the slit lamp and confirmed by specular microscopy. Histopathological examination of corneas collected from the patients who underwent penetrating keratoplasty (PKP) was also done.
###end p 17
###begin title 18
Mutation analysis
###end title 18
###begin p 19
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 351 359 351 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
DNA was isolated from peripheral blood lymphocytes using the protocol described by Miller et al., (1988) [21]. Polymerase chain reaction (PCR) was used to amplify the 2 exons of COL8A2 (NM_005202) using 16 sets of oligonucleotide primer pairs and PCR conditions were followed as previously described in the literature [12]. For mutational analysis of SLC4A11 (NM_032034) gene, all the coding exons of SLC4A11 and their flanking splice junctions were amplified by means of PCR using the primers reported elsewhere [20]. The PCR products were purified using a gel extraction kit (Amersham Biosciences, Piscataway, NJ), and bi-directional sequencing was performed using an ABI 3130 sequencer (Applied Biosystems, Foster City, CA).
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
Data was analysed using Stata 8 (Stata, college station, TX). Statistical differences in allele and genotype frequencies between the case and the control groups were determined using Pearson's chi-squared test or by Fischer's exact test respectively.
###end p 21
###begin title 22
Prediction of splice site alteration
###end title 22
###begin p 23
To identify whether the variants found are causing any splice site alteration, a program for recognizing the splice sites was used .
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 216 219 <span type="species:ncbi:9606">men</span>
###xml 232 237 <span type="species:ncbi:9606">women</span>
###xml 852 860 <span type="species:ncbi:9606">patients</span>
###xml 864 872 <span type="species:ncbi:9606">patients</span>
Eighty unrelated patients with a diagnosis of either early or late-onset FECD were enrolled in the study. All of them were sporadic cases and no family history of disease was observed. Among the 80 patients, 27 were men and 53 were women. Age of onset of symptoms was between 17 to 76 years. The probands' onset of symptoms within 40 years of age was considered as early onset and above 40 years as late onset. Fifteen cases came under the early onset category in which 5 were males and 10 were females. Their age ranged from 26 to 40 years with an average of 33.6 years (Standard Deviation (SD) 5.1). The age of 65 late onset cases ranged from 42 to 76 years with an average range of 55 years (SD 8.3) including 20 males and 45 females. The 100 unrelated controls age range was 25 to 70 years with an average of 50 years (SD 12.42). Among the 80 FECD patients 37 patients underwent PKP (bilateral- 11, unilateral- 26), the age at surgery was between 36 to 77 years and all the cases were confirmed to have FECD by histopathological examination. Epithelial, stromal edema and thickened Descemet membrane was seen in all the buttons including the presence of guttae in longstanding cases.
###end p 25
###begin p 26
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 294 299 294 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1a, b</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
Screening of the COL8A2 gene in the affected patients did not reveal any of the previously identified pathogenic mutations associated with FECD [12,13,15], and [16]. The reported c.464G>A (p.Arg155Gln) [12,16] variant, novel variants c.1610G>A (p.Asp537Asn) and c.1643A>G (p.Asn548Ser) (Figure 1a, b) were found both in controls and patients with statistically insignificant association with the disease. Reported silent variants c.112G>A (p. =), c.1485G>A (p. =) [12] were also identified. The p values of these alleles showed significant association with the disease however the odds ratio (OR) was significantly lesser on comparing the disease with controls (Table 1).
###end p 26
###begin p 27
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sequence chromatograms of the FECD patients showing the variants along with the controls</bold>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Sequence chromatograms of the FECD patients showing the variants along with the controls. a, b. Novel variants identified in the COL8A2 gene. c, d. Novel variants identified in SLC4A11 gene. The underline marks the mutated codon. The arrow indicates heterozygous state of the sequence.
###end p 27
###begin p 28
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
Allele and genotype frequencies of COL8A2 and SLC4A11 variants
###end p 28
###begin p 29
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
The numbering is based on the complementary DNA sequence, with +1 corresponding to the A of the ATG translation initiation codon. All the variants identified both in COL8A2 and SLC4A11 were shown in this table. Asterisk (*) indicates novel variants identified in this study. NS means Not Significant. P value is considered to be statistically significant if P < 0.05.
###end p 29
###begin p 30
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 133 138 133 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1c, d</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 378 385 378 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 389 397 389 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
SLC4A11 gene screening did not identify any pathogenic mutation. However 2 novel variants c.1659C>T (p. =), c.1974C>T (p. =) (Figure 1c, d) and 3 reported variants c.405G>A (p. =), c.481A>C (p. =), c.639G>A (p. =) [19] were identified. None of the variants were found to have any statistically significant association with the disease (Table 1). Moreover variants identified in COL8A2 and SLC4A11 did not seem to alter any splice site.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 694 701 694 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 620 628 <span type="species:ncbi:9606">patients</span>
The exact cause of FECD is still unknown. To understand the pathogenesis, we screened for COL8A2 and SLC4A11 gene variants in our study. Previous studies in other ethnic groups identified pathogenic mutations in COL8A2 in association with FECD [12-16]. Biswas et al., [12] reported that p.Gln455Lys was detected in 3 early onset FECD families originating from Northern England and Australia. Also in their study, missense mutations p.Arg155Gln, p.Arg304Gln and p.Arg434His were identified in the common, late onset form of FECD. Similar to this report the heterozygous p.Gln455Lys mutation was also identified in Korean patients with FECD [16]. Gottsch et al., [13] reported the segregation of COL8A2 p.Leu450Trp with the disease phenotype in American familial FECD with early onset subtype. A study by Liskova et al., also observed the same mutation in a British family with early-onset FECD [15].
###end p 32
###begin p 33
###xml 419 427 417 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 649 657 647 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 699 701 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 689 697 <span type="species:ncbi:9606">patients</span>
At birth, the normal endothelial cells start producing the posterior non-banded layer and continue to add material throughout life. In FECD and CHED2, Descemet membrane may appear thickened as the posterior layer is attenuated or absent and is replaced by an abnormal banded layer (varying from 14 to 20 mum, unlike the normal thickness 12 mum) due to endothelial dysfunction. This common clinical feature implies that SLC4A11 gene, the causative gene for CHED2 may play a role in FECD, even though the onset and symptoms of CHED2 and FECD are completely dissimilar. This is supported by the identification of heterozygous missense mutations in the SLC4A11 gene in Chinese and Indian FECD patients [19].
###end p 33
###begin p 34
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 598 605 598 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 825 832 825 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
In the present study we did not identify any pathogenic mutations in COL8A2 in association with FECD. Even though association of c.112G>A (p. =) and c.1485G>A (p. =) was identified with FECD patients, these mutations may not be considered as pathogenic because they do not produce any change in the encoded amino acid and also do not alter the splice site. Similarly a study by Afshari et al., [10] did not identify p.Leu450Trp and p.Gln455Lys variants in their study of screening 92 FECD patients. Kobayashi et al., [22] and Mok et al., [16] observed p.Arg155Gln and p.Thr502Met variations in the COL8A2 gene but there were no statistically significant differences in the frequencies of these 2 variations between the affected individuals and control subjects. In other 4 independent studies no mutations were identified in COL8A2 in association with both early and late-onset FECD [23-26].
###end p 34
###begin p 35
###xml 3 11 3 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 293 301 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 361 369 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
In SLC4A11 screening, we identified 2 novel and 3 reported silent variants which had no significant association with FECD and did not identify any pathogenic variants. By the screening of 25 Indian FECD cases Vithana et al., identified a presumed pathogenic variant c.1195G>A (p.Glu399Lys) in SLC4A11 in a single sporadic case. Though they found association of SLC4A11 with FECD, the mutations contribute to only 5% of the genetic burden of the disease [19].
###end p 35
###begin title 36
Conclusions
###end title 36
###begin p 37
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC4A11 </italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
This is the first report analysing the COL8A2 gene in association with Indian FECD patients and we additionally studied the SLC4A11 gene in large number of Indian cohort. In the patients screened, we did not identify any pathogenic variants in both the genes making it unlikely that single nucleotide polymorphisms or mutations in them cause FECD. The possibility of pathogenic changes being within the promoter, intronic or untranslated non coding regions of these genes playing a role in the pathogenesis of FECD has not been excluded in this study.
###end p 37
###begin p 38
Together with information from previous investigations, our study suggests that locus heterogeneity exist for FECD, wherein mutations of several genes on different chromosomes may produce a common disease phenotype. In addition to the genomic approach, proteonomic approach may also shed light on the disease pathogenesis.
###end p 38
###begin title 39
Competing interests
###end title 39
###begin p 40
The authors declare that they have no competing interests.
###end p 40
###begin title 41
Authors' contributions
###end title 41
###begin p 42
BH involved in acquisition of data, analysis and interpretation of data, statistical analysis and drafting of the manuscript. MS examined and recruited the cases, involved in planning the study and revising the manuscript. JAK examined and recruited the cases, involved in drafting of the manuscript and revising the manuscript. NVP examined and recruited the cases, involved in planning the study and revising the manuscript. PS designed the study and critically reviewed and modified the manuscript. All authors have read the final version of the manuscript and approved it for publication.
###end p 42
###begin title 43
Pre-publication history
###end title 43
###begin p 44
The pre-publication history for this paper can be accessed here:
###end p 44
###begin p 45

###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
The authors are grateful to all the members for their participation in this study; we thank VR. Muthukkaruppan, Director of Research, Aravind Medical Research Foundation, for providing many helpful discussions; we are thankful to Dr. R. Shanthi for addressing the pathological findings; we thank Ms. Prasanthi Namburi for her assistance in sequencing; we thank Dr. Ramyadevi, S. Ananthi and Dr. Gowri priya for the critical reading of the manuscript; we also thank A. Gomathi, D. Muthuselvi and P. Pappathi for providing technical assistance; The study was supported by Department of Science and Technology, India and TIFAC-CORE in diabetic retinopathy.
###end p 47
###begin article-title 48
Classification of corneal endothelial disorders based on neural crest origin
###end article-title 48
###begin article-title 49
Dystrophia epithelialis corneae
###end article-title 49
###begin article-title 50
Fuchs' endothelial dystrophy of the cornea
###end article-title 50
###begin article-title 51
The corneal endothelium. Normal and pathologic structure and function
###end article-title 51
###begin article-title 52
Inheritance of Fuchs' endothelial dystrophy
###end article-title 52
###begin article-title 53
Hereditary Fuchs' dystrophy
###end article-title 53
###begin article-title 54
Corneal endothelial dystrophy. A study of 64 families
###end article-title 54
###begin article-title 55
Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13
###end article-title 55
###begin article-title 56
A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-21.32
###end article-title 56
###begin article-title 57
Genome-wide linkage scan in Fuchs endothelial corneal dystrophy
###end article-title 57
###begin article-title 58
Linkage of a mild late-onset phenotype of Fuchs corneal dystrophy to a novel locus at 5q33.1-q35.2
###end article-title 58
###begin article-title 59
Missense mutations in COL8A2, the gene encoding the alpha-2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy
###end article-title 59
###begin article-title 60
Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy
###end article-title 60
###begin article-title 61
Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation
###end article-title 61
###begin article-title 62
British family with early onset Fuchs endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene
###end article-title 62
###begin article-title 63
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Q455V mutation in COL8A2 is associated with Fuchs corneal dystrophy in Korean patients
###end article-title 63
###begin article-title 64
###xml 83 88 <span type="species:ncbi:9606">human</span>
Immunogold fine structural localization of extracellular matrix components in aged human cornea. I. Types I- IV collagen and laminin
###end article-title 64
###begin article-title 65
The composition of wide-spaced collagen in normal and diseased Descemet's membrane
###end article-title 65
###begin article-title 66
SLC4A11 mutations in Fuchs endothelial corneal dystrophy
###end article-title 66
###begin article-title 67
Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditaryendothelial dystrophy (CHED2)
###end article-title 67
###begin article-title 68
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 68
###begin article-title 69
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Analysis of COL8A2 gene mutation in Japanese patients with Fuchs endothelial dystrophy and posterior polymorphous dystrophy
###end article-title 69
###begin article-title 70
No pathogenic mutations identified in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophy
###end article-title 70
###begin article-title 71
Exclusion of COL8A1, the gene encoding the alpha2(VIII) chain of type VIII collagen, as a candidate for Fuchs endothelial dystrophy and posterior Polymorphous corneal dystrophy
###end article-title 71
###begin article-title 72
Analysis of the posterior polymorphous corneal dystrophy 3 gene, TCF8, in late-onset Fuchs endothelial corneal dystrophy
###end article-title 72
###begin article-title 73
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2 </italic>
No Pathogenic Mutations Identified in the COL8A2 Gene in French Families of Fuchs Corneal Dystrophy and CHED
###end article-title 73

